IMR Press / FBL / Volume 1 / Issue 7 / DOI: 10.2741/A154

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Treatment strategies of the borderline ovarian tumors
Show Less
1 Unit of Special Pelvic Surgery, Operative Laparoscopy and Hysteroscopy, 1st Institute of Obstetrics and Gynecology. University of Bologna . Via Massarenti, 13. 40138 Bologna, Italy
2 Institute of Cardiology, University of Bologna, Via Massarenti, 13. 40138 Bologna, Italy
Front. Biosci. (Landmark Ed) 1996, 1(7), 13–13;
Published: 1 December 1996

The present study was undertaken to establish the role of surgical procedures, histologic type, and stage of the tumor on the survival rate of patients with borderline ovarian tumors in a 5 to 15 years of follow-up. Data reported in the literature have shown the low malignancy of this cancer and that only the stage, but not the pathological diagnosis, is significantly influencing the survival rate of the patients. After 5 years, the survival rate of patients with tumors of stage I to stage II is 98.2% (n=567) and 81.4% (n=46), respectively, with no statistical difference. After 5 years, survival rate between tumors of stage I to stage III is 98.2% (n=567) and 79.1% (n=96), respectively (p< 0.05). The data shows that for borderline ovarian tumors, a minimally invasive surgery is warranted.

Back to top